Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 [Alliance]
      Google Scholar   
Citation:
J Clin Oncol vol 39 (no. 15_suppl) 7506
Meeting Instance:
ASCO 2021
Year:
2021
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                   
Networks:
ADM403, ALLIANCE, CA136, CAPITAL, LAPS-MA036, LAPS-MN026, LAPS-MO011, NC002, NY018   
Study
CALGB-51101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: